About Index Trending news
Analyze
Pricing
Intrexon

Intrexon

Work at Intrexon? Add yourself to this profile

Intrexon

Intrexon applies engineering principles to biology to enable products in the health, food, energy, consumer and environmental industries.
Edit Profile
More info

Elsewhere

Companies in the same industry

VG Life Sciences VG Life Sciences Genomera Genomera Outpost Medicine Outpost Medicine Helix Biopharma Corp (HBPCF) Helix Biopharma Corp (HBPCF) Symbiomix Symbiomix Entegrion Entegrion Intensity Therapeutic Intensity Therapeutic ApoGen Biotechnologies ApoGen Biotechnologies Fusion Pharmaceuticals Fusion Pharmaceuticals AbbVie AbbVie

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 6

Acquisitions 1

Apps 1
Add info
Latest funding Show all
Post-IPO equity
$57,500,000
Venture capital (Series F)
$150,000,000
Randal J. Kirk
Employees

Unknown size

Locations
Unknown
Help us complete this profile
The Motley Fool

The $100 Million Platform Intrexon Investors Forgot

Intrexon
Intrexon
The Motley Fool

Why Intrexon Won't Commercialize Fuels by 2018

Intrexon
Intrexon
The Motley Fool

Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.

Intrexon
Intrexon
Inovio Pharmaceuticals
Inovio Pharmaceuticals
The Motley Fool

Intrexon Battles Thermodynamics, but Thermodynamics Always Wins

Intrexon
Intrexon
The Motley Fool

Intrexon vs. MosquitoMate: Who Has the Better Zika Tool?

Intrexon
Intrexon
The Motley Fool

Here's Why Intrexon Corporation Was All the Buzz in May

Health Science
Intrexon
Intrexon
The Motley Fool

Regulatory Obstacles and Opportunities Facing Intrexon's Natural-Gas-to-Fuels Platform

Intrexon
Intrexon
Dominion Gas
Dominion Gas
The Motley Fool

Why Intrexon and Dominion Resources Are Excited About Natural Gas-to-Fuels

Intrexon
Intrexon
Dominion Gas
Dominion Gas
The Motley Fool

Intrexon's Risky Revenue Machine

Intrexon
Intrexon
The Motley Fool

Intrexon Delivers Revenue Growth (Again) While Avoiding Elephant in the Room

Earnings Stock markets
Intrexon
Intrexon
The Motley Fool

Intrexon Corporation Shares Were Stung in April -- Here's Why

Health Science
Intrexon
Intrexon
The Motley Fool

Is Intrexon Really a House of Cards?

Stock markets Science
Intrexon
Intrexon
The Motley Fool

What's Behind Intrexon's Steep Sell-Off Today

Intrexon
Intrexon
The Motley Fool

3 Things Needed to Make Intrexon's Zika Virus Cure a Success

Health
Intrexon
Intrexon
The Motley Fool

Intrexon Corp. Shares Soar Again on Zika Virus Concerns

Health Stock markets
Intrexon
Intrexon
The Motley Fool

Intrexon Corporation Catches Zika Fever

Health Stock markets
Intrexon
Intrexon
The Motley Fool

The Likely Reason Behind Intrexon Corporation's Soaring Share Price --

Stock markets Health
Intrexon
Intrexon
Wired

Intrexon’s Billionaire CEO Is Betting on the Most Controversial GMOs

Science
Intrexon
Intrexon